ANAVEX LIFE SCIENCES CORP's ticker is AVXL and the CUSIP is 032797300. A total of 149 filers reported holding ANAVEX LIFE SCIENCES CORP in Q2 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $106,699 | -25.8% | 25,284 | -10.5% | 0.00% | – |
| Q1 2024 | $143,742 | -44.7% | 28,240 | +1.1% | 0.00% | – |
| Q4 2023 | $260,065 | -22.5% | 27,934 | -45.5% | 0.00% | – |
| Q3 2023 | $335,733 | +30.5% | 51,257 | +61.9% | 0.00% | – |
| Q2 2023 | $257,347 | -5.8% | 31,654 | -0.7% | 0.00% | – |
| Q1 2023 | $273,323 | -2.6% | 31,893 | +5.3% | 0.00% | – |
| Q4 2022 | $280,504 | -18.0% | 30,292 | -8.7% | 0.00% | – |
| Q3 2022 | $342,000 | +15.2% | 33,191 | +11.8% | 0.00% | – |
| Q2 2022 | $297,000 | -20.6% | 29,677 | -2.2% | 0.00% | – |
| Q1 2022 | $374,000 | -95.0% | 30,348 | -93.0% | 0.00% | -100.0% |
| Q4 2021 | $7,548,000 | +1052.4% | 435,239 | +1091.7% | 0.00% | – |
| Q3 2021 | $655,000 | -95.2% | 36,521 | -93.9% | 0.00% | -100.0% |
| Q2 2021 | $13,682,000 | -18.7% | 598,498 | -46.8% | 0.00% | -25.0% |
| Q1 2021 | $16,824,000 | +1287.0% | 1,125,365 | +400.8% | 0.00% | – |
| Q4 2020 | $1,213,000 | +85.5% | 224,713 | +69.0% | 0.00% | – |
| Q2 2020 | $654,000 | – | 133,005 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AllSquare Wealth Management LLC | 51,966 | $219,297 | 0.13% |
| GSA CAPITAL PARTNERS LLP | 220,860 | $932 | 0.06% |
| SAXON INTERESTS, INC. | 26,699 | $112,670 | 0.05% |
| Hikari Power Ltd | 85,585 | $361 | 0.03% |
| Sculptor Capital LP | 371,400 | $1,567,308 | 0.03% |
| Sculptor Capital LP | 370,400 | $1,563,088 | 0.03% |
| Y-Intercept (Hong Kong) Ltd | 94,578 | $399,119 | 0.02% |
| Opus Capital Group, LLC | 32,700 | $138 | 0.02% |
| Hayek Kallen Investment Management | 11,863 | $50 | 0.02% |
| Geneos Wealth Management Inc. | 89,725 | $378,640 | 0.02% |